Parkinson's Disease Trial, Not Yet Recruiting NCT05072015 Sponsor: University Hospital, Strasbourg, France Condition: Parkinson's Disease
Back to Parkinsons Disease

Parkinson's Disease Trial, Not Yet Recruiting

NCT05072015
Not Yet Recruiting Not Applicable

voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice

Who may and may not be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who may be able to join

  • People who have been diagnosed with Parkinson's disease based on a specific set of recognised diagnostic guidelines (known as UKPDSSB criteria).
  • People who experience fluctuations in their symptoms and/or involuntary movements (dyskinesia), and whose treating doctor has determined they need an advanced treatment such as deep brain stimulation, an apomorphine pump, or a duodopa pump.
  • People who score above 20 on a standard memory and thinking assessment called the MoCA test.
  • People who are older than 21 years of age.
  • People who have signed the study consent form agreeing to take part in the trial.

Who may not be able to join

Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.

  • People who have not given their consent to participate in the trial.
  • People who have a form of parkinsonism other than Parkinson's disease (for example, other conditions that can look similar to Parkinson's disease).
  • People who score below 20 on the MoCA memory and thinking assessment.
  • People whose treating doctor has determined they do not need an advanced (second-line) treatment.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 31 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Mathieu ANHEIM, Les Hôpitaux Universitaires de Strasbourg

Phone: +33 3 88 12 85 35

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Not Yet Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
1 February 2022
Est. completion
1 February 2022

This date has passed while the registry still lists the trial as open to participants. Sponsors often update a trial's status without revising its projected end date, so it may well still be recruiting — but the record is out of date in at least one respect. Check with the study contact before relying on either.

Where this trial is recruiting

🇫🇷 France

Primary endpoints

MDS UPDRS IV (Movement Disorder Society - Unified Parkin-son Disease Rating Scale) score improvement

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 31 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov